Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,870 | 483 | 75.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,680 | 1 | 18.5% |
| Consulting Fee | $360.00 | 1 | 4.0% |
| Education | $175.08 | 4 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corium, LLC | $2,443 | 29 | $0 (2024) |
| ABBVIE INC. | $1,438 | 123 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $851.75 | 72 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $741.30 | 48 | $0 (2022) |
| Allergan, Inc. | $715.76 | 51 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $522.28 | 36 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $427.65 | 27 | $0 (2024) |
| ITI, Inc. | $314.92 | 22 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $261.76 | 13 | $0 (2024) |
| Lundbeck LLC | $257.35 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $772.77 | 49 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($254.94) |
| 2023 | $2,796 | 62 | Corium, LLC ($2,241) |
| 2022 | $1,092 | 71 | ABBVIE INC. ($369.14) |
| 2021 | $1,808 | 130 | AbbVie Inc. ($531.68) |
| 2020 | $724.52 | 48 | Allergan, Inc. ($307.18) |
| 2019 | $859.17 | 64 | Allergan Inc. ($248.91) |
| 2018 | $367.87 | 23 | Avanir Pharmaceuticals, Inc. ($109.36) |
| 2017 | $664.72 | 42 | Shire North American Group Inc ($168.64) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $34.65 | General |
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Neuropsychiatry | ||||||
| 08/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Edward Case, MD
Dr. Edward Case, MD is a Psychiatry healthcare provider based in Patton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407808785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Case, MD has received a total of $9,085 in payments from pharmaceutical and medical device companies, with $772.77 received in 2024. These payments were reported across 489 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($6,870).
Practice Information
- Specialty Psychiatry
- Location Patton, CA
- Active Since 05/16/2006
- Last Updated 05/11/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407808785
Products in Payments
- Azstarys (Drug) $2,282
- VRAYLAR (Drug) $1,593
- REXULTI (Drug) $835.28
- LATUDA (Drug) $741.30
- CAPLYTA (Drug) $569.86
- NUEDEXTA (Drug) $482.21
- UBRELVY (Drug) $360.66
- AUSTEDO (Drug) $279.15
- INGREZZA (Drug) $261.76
- QULIPTA (Drug) $200.56
- AZSTARYS (Drug) $160.86
- MYDAYIS (Drug) $155.95
- Trintellix (Drug) $141.36
- ABILIFY MYCITE (Drug) $134.87
- ABILIFY MAINTENA (Drug) $124.81
- TRINTELLIX (Drug) $107.51
- VYVANSE (Drug) $98.38
- SUNOSI (Drug) $54.72
- Nuedexta (Drug) $54.21
- Auvelity (Drug) $52.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Patton
Dr. Barbara Strong, M.d, M.D
Psychiatry — Payments: $5,794
Jeffrey Walsh, M.d, M.D
Psychiatry — Payments: $4,878
Dr. My Kha, M.d, M.D
Psychiatry — Payments: $4,657
Dr. Juvvala Reddy, M.d, M.D
Psychiatry — Payments: $3,619
Anicia Policar, M.d, M.D
Psychiatry — Payments: $1,580
Bobby Kaura, M.d, M.D
Psychiatry — Payments: $1,246